Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[Somatic oncogenic activating mutations in FGFR3 and/or PIK3CA have recently been described in benign epithelial cutaneous lesions that never progress to malignancy (seborrheic keratoses and epidermal nevi).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP358590.RAR4-bs6Kq3x1dOK44_4I1Jg4C_Kc1XBVfS2p5kovV2fg130_assertion description "[Somatic oncogenic activating mutations in FGFR3 and/or PIK3CA have recently been described in benign epithelial cutaneous lesions that never progress to malignancy (seborrheic keratoses and epidermal nevi).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP358590.RAR4-bs6Kq3x1dOK44_4I1Jg4C_Kc1XBVfS2p5kovV2fg130_provenance.
• NP393666.RAUv39jgwSFlnPgd1hO047S0ZHfm8TMyqPgIqCTxhmzRE130_assertion description "[Somatic oncogenic activating mutations in FGFR3 and/or PIK3CA have recently been described in benign epithelial cutaneous lesions that never progress to malignancy (seborrheic keratoses and epidermal nevi).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP393666.RAUv39jgwSFlnPgd1hO047S0ZHfm8TMyqPgIqCTxhmzRE130_provenance.
• assertion description "[Somatic oncogenic activating mutations in FGFR3 and/or PIK3CA have recently been described in benign epithelial cutaneous lesions that never progress to malignancy (seborrheic keratoses and epidermal nevi).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Somatic oncogenic activating mutations in FGFR3 and/or PIK3CA have recently been described in benign epithelial cutaneous lesions that never progress to malignancy (seborrheic keratoses and epidermal nevi).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP299547.RA_z-IaRKFeiaEWoS2PXg7liAUYIurBuyjZjJjPzjm6aY130_assertion description "[Somatic oncogenic activating mutations in FGFR3 and/or PIK3CA have recently been described in benign epithelial cutaneous lesions that never progress to malignancy (seborrheic keratoses and epidermal nevi).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP299547.RA_z-IaRKFeiaEWoS2PXg7liAUYIurBuyjZjJjPzjm6aY130_provenance.
• NP400939.RAf-LSqMakCBiIQNxNdp1Rd3qlAvhtGm7j7nIVT9Cv7bY130_assertion description "[Somatic oncogenic activating mutations in FGFR3 and/or PIK3CA have recently been described in benign epithelial cutaneous lesions that never progress to malignancy (seborrheic keratoses and epidermal nevi).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP400939.RAf-LSqMakCBiIQNxNdp1Rd3qlAvhtGm7j7nIVT9Cv7bY130_provenance.
• assertion description "[Somatic oncogenic activating mutations in FGFR3 and/or PIK3CA have recently been described in benign epithelial cutaneous lesions that never progress to malignancy (seborrheic keratoses and epidermal nevi).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Somatic oncogenic activating mutations in FGFR3 and/or PIK3CA have recently been described in benign epithelial cutaneous lesions that never progress to malignancy (seborrheic keratoses and epidermal nevi).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP689788.RAA37fLysF_2qCkQXXUu8M2K4fM0jHWa-zauIPrvEvH2M130_assertion description "[Somatic oncogenic activating mutations in FGFR3 and/or PIK3CA have recently been described in benign epithelial cutaneous lesions that never progress to malignancy (seborrheic keratoses and epidermal nevi).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP689788.RAA37fLysF_2qCkQXXUu8M2K4fM0jHWa-zauIPrvEvH2M130_provenance.
• NP621601.RACPQPsW9UDPSWbjjFLW3h--2RCzgH7zRc_HAmOf1eXPk130_assertion description "[Somatic oncogenic activating mutations in FGFR3 and/or PIK3CA have recently been described in benign epithelial cutaneous lesions that never progress to malignancy (seborrheic keratoses and epidermal nevi).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP621601.RACPQPsW9UDPSWbjjFLW3h--2RCzgH7zRc_HAmOf1eXPk130_provenance.
• NP689786.RAXOkn-xf2KV64WyO5DCSHoku1_bBdhZRzMckkieqY1PA130_assertion description "[Somatic oncogenic activating mutations in FGFR3 and/or PIK3CA have recently been described in benign epithelial cutaneous lesions that never progress to malignancy (seborrheic keratoses and epidermal nevi).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP689786.RAXOkn-xf2KV64WyO5DCSHoku1_bBdhZRzMckkieqY1PA130_provenance.
• NP689785.RAvwM6sm8GhMHVmU6k09PyJrNJPnvN9yaWmrwjmBex8Qs130_assertion description "[Somatic oncogenic activating mutations in FGFR3 and/or PIK3CA have recently been described in benign epithelial cutaneous lesions that never progress to malignancy (seborrheic keratoses and epidermal nevi).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP689785.RAvwM6sm8GhMHVmU6k09PyJrNJPnvN9yaWmrwjmBex8Qs130_provenance.
• NP401105.RA8NI5LwKzO1sUd2xpxVicam_7Bjq58XyPrFri-Z0tAqs130_assertion description "[Somatic oncogenic activating mutations in FGFR3 and/or PIK3CA have recently been described in benign epithelial cutaneous lesions that never progress to malignancy (seborrheic keratoses and epidermal nevi).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP401105.RA8NI5LwKzO1sUd2xpxVicam_7Bjq58XyPrFri-Z0tAqs130_provenance.
• NP621028.RA834SKAVoDfljOSQXYaOnUS9QnFkOJLNBstD96NBVF8M130_assertion description "[Somatic oncogenic activating mutations in FGFR3 and/or PIK3CA have recently been described in benign epithelial cutaneous lesions that never progress to malignancy (seborrheic keratoses and epidermal nevi).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP621028.RA834SKAVoDfljOSQXYaOnUS9QnFkOJLNBstD96NBVF8M130_provenance.
• NP689787.RAxnBqVPrWI3NHcY2Vd12oGOCWLTJLUMFR7NZ_Vg_GcXk130_assertion description "[Somatic oncogenic activating mutations in FGFR3 and/or PIK3CA have recently been described in benign epithelial cutaneous lesions that never progress to malignancy (seborrheic keratoses and epidermal nevi).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP689787.RAxnBqVPrWI3NHcY2Vd12oGOCWLTJLUMFR7NZ_Vg_GcXk130_provenance.